These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
626 related articles for article (PubMed ID: 21372215)
1. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents. Buddingh EP; Kuijjer ML; Duim RA; Bürger H; Agelopoulos K; Myklebost O; Serra M; Mertens F; Hogendoorn PC; Lankester AC; Cleton-Jansen AM Clin Cancer Res; 2011 Apr; 17(8):2110-9. PubMed ID: 21372215 [TBL] [Abstract][Full Text] [Related]
2. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120 [TBL] [Abstract][Full Text] [Related]
3. High WT1 expression is associated with very poor survival of patients with osteogenic sarcoma metastasis. Srivastava A; Fuchs B; Zhang K; Ruan M; Halder C; Mahlum E; Weber K; Bolander ME; Sarkar G Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4237-43. PubMed ID: 16857797 [TBL] [Abstract][Full Text] [Related]
4. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442 [TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide. Bruheim S; Xi Y; Ju J; Fodstad O Clin Cancer Res; 2009 Dec; 15(23):7161-9. PubMed ID: 19920113 [TBL] [Abstract][Full Text] [Related]
7. Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data. Kuijjer ML; Rydbeck H; Kresse SH; Buddingh EP; Lid AB; Roelofs H; Bürger H; Myklebost O; Hogendoorn PC; Meza-Zepeda LA; Cleton-Jansen AM Genes Chromosomes Cancer; 2012 Jul; 51(7):696-706. PubMed ID: 22454324 [TBL] [Abstract][Full Text] [Related]
8. Expression of major vault protein gene in osteosarcoma patients. Dalla-Torre CA; de Toledo SR; Yoshimoto M; Petrilli AS; Andrade JA; Chilton-MacNeill S; Squire JA; Zielenska M J Orthop Res; 2007 Jul; 25(7):958-63. PubMed ID: 17415755 [TBL] [Abstract][Full Text] [Related]
9. KAI-1 expression in pediatric high-grade osteosarcoma. Leavey PJ; Timmons C; Frawley W; Lombardi D; Ashfaq R Pediatr Dev Pathol; 2006; 9(3):219-24. PubMed ID: 16944980 [TBL] [Abstract][Full Text] [Related]
10. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Laverdiere C; Hoang BH; Yang R; Sowers R; Qin J; Meyers PA; Huvos AG; Healey JH; Gorlick R Clin Cancer Res; 2005 Apr; 11(7):2561-7. PubMed ID: 15814634 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma. Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275 [TBL] [Abstract][Full Text] [Related]
12. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma. Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860 [TBL] [Abstract][Full Text] [Related]
13. [Apoptosis antagonizing transcription factor is a gene highly expressed in highly metastatic human osteosarcoma cell lines]. Yin JN; Fan QY; Hao XB; Yang N Ai Zheng; 2002 Feb; 21(2):127-31. PubMed ID: 12479059 [TBL] [Abstract][Full Text] [Related]
14. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Patiño-García A; Zalacain M; Folio C; Zandueta C; Sierrasesúmaga L; San Julián M; Toledo G; De Las Rivas J; Lecanda F Clin Cancer Res; 2009 Aug; 15(16):5082-91. PubMed ID: 19671856 [TBL] [Abstract][Full Text] [Related]
15. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis. Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852 [TBL] [Abstract][Full Text] [Related]
16. COPS3 amplification and clinical outcome in osteosarcoma. Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of macrophage infiltration in leiomyosarcomas. Lee CH; Espinosa I; Vrijaldenhoven S; Subramanian S; Montgomery KD; Zhu S; Marinelli RJ; Peterse JL; Poulin N; Nielsen TO; West RB; Gilks CB; van de Rijn M Clin Cancer Res; 2008 Mar; 14(5):1423-30. PubMed ID: 18316565 [TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas. Park HR; Min K; Kim HS; Jung WW; Park YK Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723 [TBL] [Abstract][Full Text] [Related]
19. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas. Entz-Werlé N; Marcellin L; Gaub MP; Guerin E; Schneider A; Berard-Marec P; Kalifa C; Brugiere L; Pacquement H; Schmitt C; Tabone MD; Jeanne-Pasquier C; Terrier P; Dijoud F; Oudet P; Lutz P; Babin-Boilletot A J Clin Oncol; 2005 Apr; 23(10):2248-55. PubMed ID: 15800315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]